LITS
LITS
NASDAQ · Biotechnology

Lite Strategy Inc

$0.88
-0.02 (-2.01%)
As of Jun 23, 5:15 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +4,245.1% upside
Low Target $26.78
Average Target $38.05
High Target $46.02
Current Price $0.88
Current
$0.88
Target
$38.05
$26.78 $38.05 avg $46.02
Scenario Analysis
Bear Case
$26.78
2,958.1%
Low target
Base Case
$38.05
+4,245.1%
Avg target
Bull Case
$46.02
+5,155.2%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$9.00
-90.3% from high
52-Week Low
$0.69
+27.1% from low
Target vs 52W High
$38.05
+322.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%